Delivery Order SPE2DX22D0010-SPE2D825FHD99
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $19,082.45. This firm fixed-price delivery order, which is expected to be completed by August 22, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- On September 16, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $23,558.87 to AmerisourceBergen Drug Corp for the supply of Concerta ER (extended-release) 36 mg tablets. This competitive, firm fixed-price delivery order, which carries no set-aside designation, is scheduled for completion by September 17, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $11,257.85. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- On August 13, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $52,496.58 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count units). This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $9,978.49. This non-set-aside, firm fixed-price contract is scheduled for completion by July 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $2,302.04. This firm fixed-price delivery order, with an ultimate completion date of July 11, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $10,648.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with a completion date of August 6, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Concerta ER 36 mg tablets (100-count packaging) valued at $2,786.94. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by July 30, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Concerta 54mg tablets (100-count units) valued at $12,350.28 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Concerta ER 27 mg tablets (100 count) with a ceiling value of $23,371.40. This firm fixed price delivery order, which concludes on September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The award was competitively...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHD99Delivery Order
This delivery order, awarded July 24, 2025, represents a competitive, non-set-aside contract awarded to AmerisourceBergen Drug Corp for the supply of Concerta ER (extended-release) tablets at 36 mg strength. The contract, valued at $32,045.46 with a completion date of July 25, 2025, is funded by the Defense Department's Medical Supply Chain and performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The firm fixed-price delivery order structure reflects standardized federal pharmaceutical procurement practices for time-sensitive medical supply needs. This award is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. The delivery order for Concerta ER tablets represents a single transaction within this larger framework, supporting the Defense Health Agency and other federal healthcare systems' pharmaceutical requirements for attention deficit treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.0k | 7/24/25 |